Repository logo
 
Publication

Association of statin therapy with blood pressure control in hypertensive hypercholesterolemic outpatients in clinical practice

dc.contributor.authorMorgado, Manuel
dc.contributor.authorRolo, Sandra
dc.contributor.authorMacedo, Ana Filipa
dc.contributor.authorCastelo-Branco, Miguel
dc.date.accessioned2011-04-05T21:28:24Z
dc.date.available2011-04-05T21:28:24Z
dc.date.issued2011-01
dc.description.abstractBackground: Some clinical evidence revealed that statins, apart from lowering cholesterol levels, also have an antihypertensive effect. Our aim was to evaluate the existence of a possible association of statin therapy with blood pressure (BP) control in clinical practice. Materials and Methods: Patients attending a hypertension/ dyslipidemia clinic were prospectively evaluated. Those patients with a diagnosis of stage 1 hypertension and hypercholesterolemia who consented to participate were included in the study, either in the statin group (when taking a statin) or in the control group (when not taking a statin). Exclusion criteria included dementia, pregnancy, or breastfeeding, and history or evidence of stage 2 hypertension. Detailed clinical information was prospectively obtained from medical records. A total of 110 hypertensive patients were assigned to the study (82 in the statin group and 28 in the control group). Results: Although there were no signifcant differences (P > 0.05) in both groups concerning gender, body mass index, antihypertensive pharmacotherapy, and serum levels of high-density lipoprotein cholesterol and triglycerides, a higher BP control was observed in the statin group (P = 0.002). Signifcantly lower systolic BP (−6.7 mmHg, P = 0.020) and diastolic BP (−6.4 mmHg, P = 0.002) levels were reported in the statin group. Serum levels of low-density lipoprotein were also signifcantly lower in the statin group (P < 0.001). Conclusions: This observational study detected an association of statin therapy with BP control in hypertensive hypercholesterolemic patients in clinical practice. These fndings raise the possibility that statin therapy may be useful for BP control in the studied population.por
dc.description.sponsorshipWe thank the FCT (Fundação para a Ciência e a Tecnologia) for supporting the fellowship grant (no. SFRH/BD/36756/2007) attributed to Manuel Morgadopor
dc.identifier.doi10.4103/0975-3583.78596
dc.identifier.issn0975-3583
dc.identifier.urihttp://hdl.handle.net/10400.6/666
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherPeng Zhoupor
dc.relationDESENVOLVIMENTO E AVALIAÇÃO DE ESTRATÉGIAS PARA AUMENTAR A ADESÃO À TERAPÊUTICA FARMACOLÓGICA ANTI-HIPERTENSORA
dc.relation.ispartofseriesVol 2 / Issue 1 / Jan-Mar 2011;
dc.relation.publisherversionhttp://www.jcdronline.com/temp/JCardiovascDisRes2144-612623_170102.pdfpor
dc.subjectAntihypertensivespor
dc.subjectBlood pressurepor
dc.subjectHypercholesterolemiapor
dc.subjectHypertensionpor
dc.subjectPortugalpor
dc.subjectStatinspor
dc.titleAssociation of statin therapy with blood pressure control in hypertensive hypercholesterolemic outpatients in clinical practicepor
dc.typejournal article
dspace.entity.typePublication
oaire.awardTitleDESENVOLVIMENTO E AVALIAÇÃO DE ESTRATÉGIAS PARA AUMENTAR A ADESÃO À TERAPÊUTICA FARMACOLÓGICA ANTI-HIPERTENSORA
oaire.awardURIinfo:eu-repo/grantAgreement/FCT//SFRH%2FBD%2F36756%2F2007/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/PIDDAC/SFRH%2FBD%2F36756%2F2007/PT
oaire.citation.endPage49por
oaire.citation.issueVol 2 / Issue 1 / Jan-Mar 2011por
oaire.citation.startPage44por
oaire.citation.titleJournal of Cardiovascular Disease Researchpor
oaire.fundingStreamPIDDAC
person.familyNameNunes Vicente Passos Morgado
person.familyNameCASTELO-BRANCO CRAVEIRO SOUSA
person.givenNameManuel Augusto
person.givenNameMIGUEL
person.identifierAAG-4910-2021
person.identifierF-7869-2010
person.identifier.ciencia-id7617-9FDC-2D9D
person.identifier.ciencia-idE91D-05E2-A2C1
person.identifier.orcid0000-0003-2112-2835
person.identifier.orcid0000-0002-6191-5912
person.identifier.scopus-author-id55955252600
person.identifier.scopus-author-id36730721300
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsopenAccesspor
rcaap.typearticlepor
relation.isAuthorOfPublication7c614887-225f-44d4-b467-3cc34e44a98b
relation.isAuthorOfPublication67c51098-b7e8-4164-bcfe-528b50e11bfd
relation.isAuthorOfPublication.latestForDiscovery67c51098-b7e8-4164-bcfe-528b50e11bfd
relation.isProjectOfPublicationfb08de9b-504d-45bb-aecc-5a43c9948e87
relation.isProjectOfPublicationbac02bc8-6a5d-48cd-8b5a-528b2f7380f1
relation.isProjectOfPublication.latestForDiscoverybac02bc8-6a5d-48cd-8b5a-528b2f7380f1

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
JCDR-2-44.pdf
Size:
979.88 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: